Last reviewed · How we verify
NCT06302868
Telemedicine-Based Virtual Reality Clinic for the Treatment of Phobias
NA trial testing Telemedicine Exposure Therapy Using Photos and Videos in Arachnophobia in 30 participants. Status unknown.
1 August 2024
Quick facts
| Lead sponsor | University of South Florida |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 3 October 2023 |
| Primary completion | 1 August 2024 |
| Estimated completion | 1 August 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Telemedicine Exposure Therapy Using Photos and Videos
- Telemedicine-Based Virtual Reality Exposure Therapy
Conditions studied
- Arachnophobia — all drugs for Arachnophobia →
- Cynophobia — all drugs for Cynophobia →
- Ophidiophobia — all drugs for Ophidiophobia →
Sponsor
University of South Florida
Who can join
18 and older, any sex, with Arachnophobia or Cynophobia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to assess the feasibility of conducting a randomized controlled efficacy trial comparing the delivery of exposure therapy via a telemedicine-based virtual reality clinic (Doxy.me VR) vs. standard telemental health (TMH) to adults with intense fear of dogs, snakes, and/or spiders. The secondary purpose is to preliminarily examine the efficacy of using Doxy.me VR vs. TMH in reducing phobia severity.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Examining a Telemedicine-Based Virtual Reality Clinic in Treating Adults With Specific Phobia: Protocol for a Feasibility Randomized Controlled Efficacy Trial.
Schuler KR, Ong T, Welch BM, Craggs JG, et al · · 2025 · PMID 40209221 · DOI 10.2196/65770
Verify or expand the search:
- PubMed search for NCT06302868
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of South Florida trials
Trials by the same sponsor.
- NCT07529366 — Pharmacist-Led Continuous Glucose Monitoring for Prediabetes · recruiting
- NCT07342569 — The WeACT Program for Family Caregivers of People Living With Dementia · NA · not yet recruiting
- NCT07502378 — Effect of Acoltremon Ophthalmic Solution 0.003% on Signs and Symptoms of Ocular Surface Disease in Stage I Neurotrophic · Phase 4 · recruiting
- NCT07241260 — Hydrate Heroes for Improving Brain Function & Mood · NA · not yet recruiting
- NCT06377215 — Understanding Aided Speech Perception in Noise · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06302868 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of South Florida
- Last refreshed: 12 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06302868.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing